Combined blockade of <scp>GPX4</scp> and activated <scp>EGFR</scp>/<scp>HER3</scp> bypass pathways inhibits the development of <scp>ALK</scp>‐inhibitor‐induced tolerant persister cells in <scp><i>ALK</i></scp>‐fusion‐positive lung cancerKoh Furugaki, Shigeki Yoshiura|Molecular Oncology|2024Cited by 7